Menu Investors Shareholder information Manage your shares Manage your shares You can manage your UK shares and request changes to your details on the Equiniti Shareview website. If you register with Equiniti Shareview you will be able to make the following changes online: change address details change bank account details for dividend payments change account designation Your dividend payments GSK is simplifying the way it makes dividend payments. From April 2020, payments to shareholders will be made by direct credit only. You will need to provide Equiniti, our registrar, with your bank details for your dividends to be paid directly to your nominated account by direct credit. If you do not provide this information, you will still receive an annual dividend statement; however, you will not receive the money until your bank details are received, after which payment will be credited to your bank or building society account as soon as possible. Your dividends will not accrue interest while they are being held for you and there may be a fee for Equiniti to reissue payments. For further information, please see our FAQs for further information on this change. Alternatively, you can contact Equiniti. Shareholder enquiries: Equiniti Limited Aspect House Spencer Road Lancing West Sussex BN99 6DA www.shareview.co.uk (Within the UK) 0371 384 2991 (Outside the UK) +44 (0)121 415 7067 Lines open 8.30am to 5.30pm (UK time), Monday to Friday (excluding public holidays in England and Wales) Reinvest your dividends to buy more shares With the GSK Dividend Reinvestment Plan (DRIP) you can use your cash dividends to buy more shares in GSK. As an alternative to the dividend payment, your cash will be used to buy additional shares. The DRIP is a convenient, easy and cost-effective way to build your shareholding. To apply for the GSK DRIP, call 0371 384 2268 or visit www.shareview.co.uk/info/drip. US-based shareholders US-based shareholders should use the following contact details: J.P. Morgan Chase Bank Registrar: EQ Shareowner Services PO Box 64504 St. Paul MN 55164-0504 Overnight correspondence should be sent to: EQ Shareowner Services 1110 Centre Point Curve Suite 101 Mendota Heights MN 55120-4100 Website: www.shareowneronline.com Tel: +1 877 353 1154 (US toll free) Tel: +1 651 453 2128 (outside the USA) Email anytime at www.shareowneronline.com by selecting Contact Us. The Depositary also provides Global Invest Direct, an ADS purchase/sale and dividend reinvestment plan for ADR holders. Current participants in the BNY Global BuyDIRECT will receive a welcome letter via US Mail with instructions for activating their new Global Invest Direct account. Further information regarding signing up for Global Invest Direct can be obtained by visiting www.shareowneronline.com or call the above helpline number to obtain an enrollment pack. RSS Other GSK websites Market website selector GSKPro for healthcare professionals GSK Study Register Quick links COVID-19 response Behind the science About us Products Careers Investors Media Research and development Responsibility Accessibility/legal Accessibility Terms of use Cookie policy Privacy notice Modern Slavery Act statement 2020 PDF - 191.4KB Sitemap Contact us Contact us Partnerships Report a possible side effect Business to business Supplier website Business to business This is our global website, intended for visitors seeking information on GSK’s worldwide business. Our market sites can be reached by visiting our market selector. © 2001-2021 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. We use cookies GSK values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Others are optional: performance cookies show us how you use our website and features; functional cookies remember your preferences; and advertising cookies help us share relevant content.Cookie Policy Show detail ❮ OPT OUT ACCEPT ALL